Holen Sie sich die Stockscreener-App
34.78
2.23%
0.76
Handel nachbörslich:
35.28
0.50
+1.44%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TGTX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$34.02
Offen:
$34.01
24-Stunden-Volumen:
3.26M
Relative Volume:
1.49
Marktkapitalisierung:
$5.52B
Einnahmen:
$264.79M
Nettoeinkommen (Verlust:
$-14.36M
KGV:
-316.18
EPS:
-0.11
Netto-Cashflow:
$-28.11M
1W Leistung:
+4.33%
1M Leistung:
-3.72%
6M Leistung:
-23.58%
1J Leistung:
+38.79%
1-Tages-Spanne:
$33.81
$36.65
1-Wochen-Bereich:
$33.16
$36.65
52-Wochen-Spanne:
$22.92
$46.48
Tg Therapeutics Inc Stock (TGTX) Company Profile
Firmenname
Tg Therapeutics Inc
Sektor
Branche
Telefon
(212) 554-4484
Adresse
2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY
Vergleichen Sie TGTX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TGTX
Tg Therapeutics Inc
|
34.78 | 5.40B | 264.79M | -14.36M | -28.11M | -0.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tg Therapeutics Inc Stock (TGTX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-06 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2024-10-29 | Eingeleitet | TD Cowen | Buy |
| 2023-08-02 | Hochstufung | Goldman | Sell → Neutral |
| 2023-06-26 | Fortgesetzt | Jefferies | Buy |
| 2022-05-20 | Eingeleitet | BofA Securities | Underperform |
| 2022-02-23 | Bestätigt | B. Riley Securities | Buy |
| 2021-11-15 | Herabstufung | Goldman | Neutral → Sell |
| 2021-04-20 | Eingeleitet | Goldman | Neutral |
| 2021-04-19 | Bestätigt | H.C. Wainwright | Buy |
| 2020-09-01 | Eingeleitet | JP Morgan | Overweight |
| 2020-08-11 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-05 | Eingeleitet | Evercore ISI | Outperform |
| 2020-01-17 | Bestätigt | H.C. Wainwright | Buy |
| 2019-11-27 | Fortgesetzt | B. Riley FBR | Buy |
| 2019-02-06 | Fortgesetzt | Jefferies | Buy |
| 2018-09-25 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2018-03-09 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2017-12-01 | Fortgesetzt | B. Riley FBR, Inc. | Buy |
| 2017-11-14 | Fortgesetzt | H.C. Wainwright | Buy |
| 2017-04-25 | Eingeleitet | Jefferies | Buy |
| 2017-03-06 | Bestätigt | FBR & Co. | Outperform |
| 2016-10-06 | Fortgesetzt | Brean Capital | Buy |
| 2016-05-27 | Eingeleitet | SunTrust | Buy |
| 2015-12-01 | Eingeleitet | FBR Capital | Outperform |
| 2015-09-09 | Eingeleitet | Raymond James | Strong Buy |
| 2015-08-12 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-19 | Bestätigt | Brean Capital | Buy |
| 2014-12-11 | Bestätigt | ROTH Capital | Buy |
| 2014-12-10 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Tg Therapeutics Inc Aktie (TGTX) Neueste Nachrichten
Is TG Therapeutics Inc. stock oversold or undervaluedJuly 2025 Earnings & Precise Buy Zone Identification - newser.com
How TG Therapeutics Inc. stock compares to industry benchmarksGlobal Markets & Weekly Momentum Picks - newser.com
How TG Therapeutics Inc. (NKB2) stock trades under stagflationQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com
What dividend safety score for TG Therapeutics Inc. stock2025 Retail Activity & Low Risk Entry Point Tips - newser.com
Analyzing recovery setups for TG Therapeutics Inc. investorsJuly 2025 Setups & High Yield Equity Trading Tips - newser.com
Is it time to cut losses on TG Therapeutics Inc.July 2025 Intraday Action & Daily Volume Surge Signals - newser.com
How to escape a deep drawdown in TG Therapeutics Inc.Breakout Watch & Daily Chart Pattern Signal Reports - newser.com
Is TG Therapeutics Inc. stock a good choice for value investorsJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
Will TG Therapeutics Inc. stock outperform value stocksJuly 2025 Reactions & Short-Term High Return Strategies - newser.com
TG Therapeutics Inc Stock Analysis and ForecastMonthly Performance Summary & Small Investment Portfolio Growth - earlytimes.in
Tools to assess TG Therapeutics Inc.’s risk profileJuly 2025 Institutional & Scalable Portfolio Growth Methods - newser.com
How to build a dashboard for TG Therapeutics Inc. stock2025 Performance Recap & AI Driven Stock Reports - newser.com
Is TG Therapeutics Inc. stock gaining market shareWeekly Trade Report & Community Shared Stock Ideas - newser.com
Building trade automation scripts for TG Therapeutics Inc.Market Trend Summary & AI Forecast Swing Trade Picks - newser.com
Is now a turning point for TG Therapeutics Inc.Weekly Earnings Recap & Expert Approved Trade Ideas - newser.com
TG Therapeutics, Inc. $TGTX Stock Position Reduced by State of New Jersey Common Pension Fund D - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap? - Yahoo Finance
TG Therapeutics to Host Conference Call on Third Quarter 2025 Financial Results and Business Update - The Manila Times
TG Therapeutics to Host Conference Call for Third Quarter 2025 Results on November 3, 2025 - Quiver Quantitative
TG Therapeutics (NASDAQ: TGTX) schedules Q3 results call, 8:30 a.m. ET, business update - Stock Titan
Will TG Therapeutics Inc. stock attract ESG investors2025 Key Highlights & Detailed Earnings Play Strategies - newser.com
What Wall Street predicts for TG Therapeutics Inc. stock priceEarnings Trend Report & Precise Swing Trade Entry Alerts - newser.com
Yorktown Management & Research Co Inc Invests $383,000 in TG Therapeutics, Inc. $TGTX - MarketBeat
TG Therapeutics, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Published on: 2025-10-30 02:47:51 - newser.com
Finanzdaten der Tg Therapeutics Inc-Aktie (TGTX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.62%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):